Key Points
- Adtalem Global Education CEO Stephen Beard sold 2,529 shares on June 11 at an average price of $130.78, totaling about $330,743. The sale was made under a pre-arranged Rule 10b5-1 trading plan, and his ownership fell by 0.59%.
- The company recently reported better-than-expected earnings, with quarterly EPS of $1.98 versus the $1.73 consensus estimate, on revenue of $487.03 million. It also raised fiscal 2026 guidance to $7.95-$8.15 EPS.
- Analyst sentiment is mixed but generally constructive, with a Moderate Buy consensus and a target price of $155. Recent ratings included an upgrade from Wall Street Zen and price target increases from Truist Financial and Barrington Research.
Adtalem Global Education Inc. (NYSE:CVSA - Get Free Report) CEO Stephen Beard sold 2,529 shares of the firm's stock in a transaction that occurred on Thursday, June 11th. The stock was sold at an average price of $130.78, for a total transaction of $330,742.62. Following the sale, the chief executive officer owned 424,033 shares in the company, valued at $55,455,035.74. This trade represents a 0.59% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Adtalem Global Education Stock Performance
Shares of CVSA stock opened at $128.23 on Friday. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.36. The firm has a market cap of $4.36 billion, a P/E ratio of 19.97, a P/E/G ratio of 1.09 and a beta of 0.62. The business's 50 day moving average is $120.70. Adtalem Global Education Inc. has a 52 week low of $86.97 and a 52 week high of $156.26.
Adtalem Global Education (NYSE:CVSA - Get Free Report) last announced its earnings results on Thursday, May 7th. The company reported $1.98 EPS for the quarter, topping the consensus estimate of $1.73 by $0.25. The firm had revenue of $487.03 million for the quarter. Adtalem Global Education had a net margin of 12.26% and a return on equity of 20.19%. The business's quarterly revenue was up 4.5% on a year-over-year basis. During the same quarter last year, the business posted $1.92 earnings per share. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. Analysts forecast that Adtalem Global Education Inc. will post 8.04 earnings per share for the current year.
Analysts Set New Price Targets
A number of analysts have recently issued reports on CVSA shares. Weiss Ratings reiterated a "hold (c+)" rating on shares of Adtalem Global Education in a report on Friday, May 22nd. Barrington Research reiterated an "outperform" rating and issued a $170.00 price objective on shares of Adtalem Global Education in a report on Monday, June 8th. Wall Street Zen upgraded shares of Adtalem Global Education from a "hold" rating to a "buy" rating in a report on Saturday. Zacks Research downgraded shares of Adtalem Global Education from a "strong-buy" rating to a "hold" rating in a report on Wednesday, March 25th. Finally, Truist Financial lifted their price objective on shares of Adtalem Global Education from $130.00 to $140.00 and gave the company a "buy" rating in a report on Monday, May 11th. Two research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $155.00.
Read Our Latest Research Report on CVSA
About Adtalem Global Education
(
Get Free Report)
Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.
Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
